SEHA’s Tawam Hospital in Abu Dhabi will host the UAE and wider region’s first certified workshop on Low-Dose Radiotherapy for benign diseases, marking a significant step in extending the clinical use of radiation therapy beyond cancer treatment.
Delivered over three days in collaboration with JointGlow, the programme will bring together radiation oncologists, medical physicists, radiation therapists, informatics specialists and senior healthcare administrators. The workshop is designed to develop standardised, evidence-based clinical pathways for the responsible application of Low-Dose Radiotherapy in selected benign and inflammatory conditions, guided by international best practices and measurable outcome tracking.
While clinical evidence supporting Low-Dose Radiotherapy for non-cancerous conditions continues to grow through ongoing trials, structured institutional adoption across the region has remained limited. This initiative introduces a first-of-its-kind certification framework at the institutional level, establishing a governed, quality-assured model for embedding this therapeutic approach into routine clinical practice.
Also read: Bundibugyo virus outbreak surpasses 900 cases in DRC and Uganda
Participating clinicians will receive individual certification alongside an institutional certification for Tawam Hospital itself. The programme will also propose unified clinical protocols and operational workflows, underpinned by a registry and governance structure built for systematic outcomes monitoring, quality assurance and long-term clinical evaluation.
Tawam Hospital is expected to anchor future Low-Dose Radiotherapy expansion across the UAE and GCC, taking on a central role in training, certification and clinical quality oversight. The workshop’s outputs are intended to serve as a practical model for nationwide programme development.
Click here to join our WhatsApp channel here
Dr. Khalid Balaraj, Chair of Oncology at SEHA’s Tawam Hospital, described the initiative as an important step in expanding safe, non-invasive treatment options for benign conditions within a structured clinical framework. Dr. Abdulrahman Bin Sumaida, Division Chief of Radiation Oncology, emphasised that the priority extends beyond implementation to ensuring the programme is scalable, sustainable and of long-term value to both patients and health systems. Dr. Khalifa Alkaabi, Consultant in Radiation Oncology, stressed the importance of rigorous governance and clinical accountability, noting that the collaboration is designed to ensure innovation is delivered safely, consistently and with measurable impact.
The workshop will include contributions from senior oncology leaders across the UAE alongside visiting international experts from JointGlow.
